SCIENTISTS from Newcastle and Oxford are collaborating to create devices which will make the process of diagnosing and monitoring Type 1 and 2 diabetes a less painful experience for those being tested.
Oxford Medical Diagnostics is developing products which give a reading of the levels of acetone in breath when blown into, creating an alternative to the traditional diabetes testing method of pricking a finger and analysing the blood.
A device designed for use by GPs and other medical professionals is expected to hit the market in the next six to eight months after finishing clinical trials, while a more affordable handheld device for home monitoring could be available within a couple of years.
Oxford Medical Diagnostics was formed in 2008, but the current set-up is the result of a merger between Oxford Medical Diagnostics, experts in Broadband Cavity Enhanced Absorption Scectroscopy from Oxford University and North East handheld breath-testing start-up EV (Medical Screening).
EV (Medical Screening) was set up in 2008 and specialised in the development of Plasma Emission Spectroscopy to analyse compounds in human breath. It was set up by former IBM director and current OMD chairman John Jack, and founders included Northumbria University’s Tim Moor and University of Newcastle emeritus professor of physics Albert Crowe.
OMD chairman John Jack said: “In 40 years of international business this is without doubt one of the most exciting business opportunities with which I have been associated.”